Skip to main content
. 2015 Dec 15;3:85. doi: 10.1186/s40478-015-0264-5

Fig. 4.

Fig. 4

BRAF and phospho-FGFR1 immunostaining. a Immunohistochemistry on section from case 5 showing tumor cells stongly labeled in the two components with an antibody against BRAF V600E. b Immunohistochemistry from case 1 showing the tumor immunoreactive with an antibody against phospho-FGFR1. Magnification x200